Researchers
Tasnim Daginawala, research coordinator
Goulnar Kasymjanova MD
Goulnar's role in the program is to support, initiate and conduct research projects relevant to the program and its effects on patients and families.
Position
- Oncology Researcher
Education
- Medical Degree, State University of Medicine, Almaty Kazakhstan
Recent Publications
- Smith BM, Schwartzman K, Kovacina B, Taylor J, Kasymjanova G, Brandao G, Agulnik J S.: Lung cancer histologies associated with emphysema on computed tomography. Lung Cancer 76:61-6, 2012
- Kasymjanova G, Macdonald N, Agulnik J S, Cohen V, Pepe C, Kreisman H, Sharma R, and Small D. The predictive value of pre-treatment inflammatory markers in advanced non-small-cell lung cancer. Current oncology (Toronto, Ont.17:52-58, 2010
- Cohen V, Agulnik J S, Ang C, Kasymjanova G, Batist G, Small D, Brandao G, Chong G, and Miller W H, Jr. Epidermal growth factor receptor mutations detected by denaturing high-performance liquid chromatography in nonsmall cell lung cancer: impact on response to therapy with epidermal growth factor receptor-tyrosine kinase inhibitors. Cancer.116:4309-4317, 2010
- Gagnon B, Abrahamowicz M, Xiao Y, Beauchamp M E, MacDonald N, Kasymjanova G, Kreisman H, and Small D. Flexible modeling improves assessment of prognostic value of C-reactive protein in advanced non-small cell lung cancer. Br J Cancer.102:1113-1122, 2010
Research Activities:
Clinical trials:
- Feasibility questionnaires
- Submission
- Amendments
- Renewals
Academic research (current):
- EGFR project
- Utility of non-surgical biopsies in the genetic profiling of non-small cell lung cancer
- TKI response correlation with biological response in advanced NSCLC
- Cluster analysis of prognostic factors in early stage NSCLC
- Prognostication in advanced lung cancer
- First line TKI treatment
Tasnim Daginawala, research coordinator